此外，根据讯飞医疗公众号最新消息，日前，讯飞医疗与天津市中医药研究院附属医院签署战略合作协 议。公司指，此次战略合作，既是讯飞医疗在智慧医疗领域拓展的重要里程碑，也是市中研附院依托科 技动能实现智慧化升级的崭新契机。 本文源自：智通财经网 智通财经获悉，讯飞医疗科技(02506)再涨超4%，截至发稿，涨4.19%，报78.35港元，成交额780.92万 港元。 消息面上，讯飞医疗科技日前公布，科大讯飞、科讯创投等共八名股东均承诺自原禁售期届满日期起至 2026年12月29日不会以任何方式减持公司H股或非上市股份。目前该八名股东合计持有公司5,575.84万 股H股，占公司H股总股本的68.25%；合计持有公司8,806.82万股股份，占公司总股本的72.86%。 ...

Core Viewpoint - iFlytek Medical Technology (02506) has seen a stock increase of over 4%, currently trading at 78.35 HKD with a transaction volume of 7.8092 million HKD, indicating positive market sentiment towards the company following recent announcements [1] Group 1: Shareholder Commitment - Eight shareholders, including iFlytek (002230) and Kexin Venture Capital, have committed not to reduce their holdings of H-shares or unlisted shares until December 29, 2026, enhancing investor confidence [1] - These eight shareholders collectively hold 55.7584 million H-shares, representing 68.25% of the total H-share capital, and a total of 88.0682 million shares, accounting for 72.86% of the company's total share capital [1] Group 2: Strategic Partnership - iFlytek Medical has signed a strategic cooperation agreement with the Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, marking a significant milestone in the company's expansion in the smart healthcare sector [1] - This partnership is seen as a new opportunity for the hospital to achieve technological upgrades through collaboration with iFlytek Medical [1]

智通财经APP获悉，讯飞医疗科技(02506)再涨超4%，截至发稿，涨4.19%，报78.35港元，成交额780.92 万港元。 此外，根据讯飞医疗公众号最新消息，日前，讯飞医疗与天津市中医药研究院附属医院签署战略合作协 议。公司指，此次战略合作，既是讯飞医疗在智慧医疗领域拓展的重要里程碑，也是市中研附院依托科 技动能实现智慧化升级的崭新契机。 消息面上，讯飞医疗科技日前公布，科大讯飞、科讯创投等共八名股东均承诺自原禁售期届满日期起至 2026年12月29日不会以任何方式减持公司H股或非上市股份。目前该八名股东合计持有公司5,575.84万 股H股，占公司H股总股本的68.25%；合计持有公司8,806.82万股股份，占公司总股本的72.86%。 ...

Group 1 - The core point of the article is that Sichuang Medical (SZ 300078) held its 16th board meeting on December 29, 2025, to discuss various proposals, including the change of the internal audit leader [1] - For the first half of 2025, Sichuang Medical's revenue composition was as follows: 53.84% from property sales, 39.28% from business intelligence, and 6.87% from smart healthcare [1] - As of the report date, Sichuang Medical's market capitalization was 4.6 billion yuan [1] Group 2 - The article also mentions a breakthrough in China's new chip technology that bypasses the limitations of lithography machines, supporting AI training and embodied intelligence, with mass production possible at 28nm and above [1]

截至发稿，思创医惠市值为49亿元。 每经头条（nbdtoutiao）——海南封关首日直击：为中国探路，全球最大自贸港如何重塑开放边界？ （记者 曾健辉） 每经AI快讯，2025年12月19日，深交所对章笠中予以处分：经查明章笠中存在以下违规行为：2017年6 月，章笠中作为思创医惠（SZ 300078，收盘价：4.35元）科技股份有限公司时任董事长兼总经理，以 思创医惠子公司医惠科技有限公司名义为其个人7600万元人民币借款提供担保。章笠中未将相关担保事 项告知思创医惠，导致思创医惠未履行相应的审议程序，未及时披露有关事项。2024年11月，因章笠中 违约，债权人提起诉讼并向法院申请财产保全，医惠科技的募集资金专项账户被冻结资金5766.25万 元。章笠中的上述行为违反了本所《创业板股票上市规则（2014年修订）》第1.4条、第3.1.5条第一款 和《创业板上市公司规范运作指引（2015年修订）》第3.1.2条、第3.1.9条、第3.1.10条的规定。2025年5 月，章笠中履行还款义务后，法院裁定解除对医惠科技5766.25万元银行存款的冻结。鉴于相关违规事 实及情节，依据本所《创业板股票上市规则》第16. ...

证券日报网讯 12月18日，海峡创新在互动平台回答投资者提问时表示，公司的主营业务集中在智慧城 市、智慧医疗领域。 （文章来源：证券日报） 证券日报网讯 12月18日，海峡创新在互动平台回答投资者提问时表示，公司的主营业务集中在智慧城 市、智慧医疗领域。 （文章来源：证券日报） ...

（编辑 袁冠琳） 证券日报网讯 12月8日，荣科科技在互动平台回答投资者提问时表示，二级市场股价受宏观经济环境、 行业周期、市场情绪、资金流向等多重因素综合影响，具有不确定性。公司始终将"做好主业"作为市值 管理的核心基础，未来将持续聚焦智慧医疗主业，提升核心业务盈利能力，以扎实的经营业绩为市值提 供长期支撑；关于公司资本运作相关事项，一切信息均以公司通过指定信息披露媒体发布的正式公告为 准。 ...

Core Viewpoint - Both Haixia Innovation and Pingtan Development announced the end of stock trading suspension and will resume trading on November 21, confirming that there are no undisclosed significant matters affecting their operations or stock prices [1][5][7]. Group 1: Company Announcements - Haixia Innovation and Pingtan Development both confirmed that their previous disclosures were accurate and that there were no significant undisclosed matters affecting their stock prices [1][5][7]. - The companies conducted internal checks and found no major changes in their operational environments or business fundamentals [5][7]. Group 2: Stock Performance - As of November 20, Haixia Innovation's stock has increased by 533.33% and Pingtan Development's stock has risen by 317.07% year-to-date [3]. - Haixia Innovation's stock price increased by 185.89% from October 27 to November 17, with three instances of abnormal price fluctuations during this period [6]. - Pingtan Development's stock price rose by 255.19% from October 17 to November 17, indicating significant volatility [7]. Group 3: Financial Performance - For the first three quarters of 2025, Haixia Innovation reported revenues of 92.06 million, a year-on-year increase of 4.75%, but a net loss of 17.24 million, showing a reduction in losses [6]. - Pingtan Development reported revenues of 1.03 billion, a year-on-year decrease of 13.04%, with a net profit of 31.23 million, reflecting a 38.39% increase compared to the previous year [9]. Group 4: Business Focus - Haixia Innovation is focusing on developing smart city solutions and expanding into smart healthcare and new energy sectors to drive sustainable growth [6]. - Pingtan Development's main business activities include forestry management, wood product processing and sales, and trade related to the Pingtan Comprehensive Experimental Zone [8].

Core Viewpoint - The company, Sichuang Medical (SZ 300078), announced a board meeting to discuss management buyout matters, indicating potential strategic shifts in ownership and governance [1] Financial Performance - For the first half of 2025, the revenue composition of Sichuang Medical was as follows: property sales accounted for 53.84%, business intelligence for 39.28%, and smart healthcare for 6.87% [1] - The current market capitalization of Sichuang Medical is 4.2 billion yuan [1]

Group 1 - The event held on August 21 in Nanning aimed to facilitate cooperation between specialized and innovative enterprises and the Guangxi region, focusing on investment needs and policy support [1] - A delegation of 52 entrepreneurs and over 20 executives from specialized and innovative enterprises gathered to explore collaboration opportunities and expand into the ASEAN market [1] - Guangxi is developing an AI growth strategy that integrates research from major cities with local resources and applications in ASEAN, positioning itself as a hub for AI cooperation between ASEAN countries and China [1] Group 2 - Companies expressed diverse and practical cooperation needs, with plans including investments of 500 million to 1 billion yuan for manufacturing bases targeting ASEAN, and over 300 million yuan for establishing 1,500 grassroots medical stations [2] - There is interest from ecological and environmental enterprises in utilizing Guangxi's coastal port resources to create a "liquid export" transfer station [2] - The event also featured three specialized exchange meetings focused on green low-carbon economy, AI and intelligent manufacturing, and new generation information technology [2]